RxDoctor Payments Data

Eisel Montero Montes de Oca, APRN

Family · Lutz, FLNPI 1477900983

Payments from drug & device makers

$1,977in general payments, 2019–2025

Across 105 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$395
  • Pfizer$364
  • Lilly USA, LLC$207
  • Exact Sciences$199
  • AstraZeneca$193
  • Dynavax Technologies Corporation$107
  • plus $513 from 16 others

What the payments were for

  • Food & beverage$1,977100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,977 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$35,982
Medicare patients
160
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol38$27,733
OzempicSemaglutide23$24,125
JardianceEmpagliflozin17$23,402
EliquisApixaban21$19,752
SymbicortBudesonide/Formoterol Fumarate14$3,154
Atorvastatin Calcium272$2,057
Rosuvastatin Calcium153$1,528
Metoprolol Succinate116$1,365
Ezetimibe42$1,167
Lisinopril185$1,123
Ventolin HfaAlbuterol Sulfate11$980
Albuterol Sulfate HfaAlbuterol Sulfate35$898
Amlodipine Besylate165$875
Losartan Potassium156$835
Gabapentin78$789

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$193$30,88752 claims
Novo NordiskOzempic$395$24,12523 claims
Boehringer IngelheimJardiance$30$23,40217 claims
PfizerEliquis$364$19,75221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Lutz

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →